Cargando…

Phase II Open Label Study of Valproic Acid in Spinal Muscular Atrophy

Preliminary in vitro and in vivo studies with valproic acid (VPA) in cell lines and patients with spinal muscular atrophy (SMA) demonstrate increased expression of SMN, supporting the possibility of therapeutic benefit. We performed an open label trial of VPA in 42 subjects with SMA to assess safety...

Descripción completa

Detalles Bibliográficos
Autores principales:	Swoboda, Kathryn J., Scott, Charles B., Reyna, Sandra P., Prior, Thomas W., LaSalle, Bernard, Sorenson, Susan L., Wood, Janine, Acsadi, Gyula, Crawford, Thomas O., Kissel, John T., Krosschell, Kristin J., D'Anjou, Guy, Bromberg, Mark B., Schroth, Mary K., Chan, Gary M., Elsheikh, Bakri, Simard, Louise R.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680034/ https://www.ncbi.nlm.nih.gov/pubmed/19440247 http://dx.doi.org/10.1371/journal.pone.0005268

Ejemplares similares

SMA CARNI-VAL TRIAL PART II: A Prospective, Single-Armed Trial of L-Carnitine and Valproic Acid in Ambulatory Children with Spinal Muscular Atrophy
por: Kissel, John T., et al.
Publicado: (2011)

SMA CARNI-VAL Trial Part I: Double-Blind, Randomized, Placebo-Controlled Trial of L-Carnitine and Valproic Acid in Spinal Muscular Atrophy
por: Swoboda, Kathryn J., et al.
Publicado: (2010)

Spinal Muscular Atrophy Biomarker Measurements from Blood Samples in a Clinical Trial of Valproic Acid in Ambulatory Adults
por: Renusch, Samantha R., et al.
Publicado: (2015)

Safety and efficacy of nusinersen in spinal muscular atrophy: The EMBRACE study
por: Acsadi, Gyula, et al.
Publicado: (2021)

Metabolic efficiency with fast spiking in the squid axon
por: Moujahid, Abdelmalik, et al.
Publicado: (2012)

Energy demands of diverse spiking cells from the neocortex, hippocampus, and thalamus
por: Moujahid, Abdelmalik, et al.
Publicado: (2014)

X Chromosome Inactivation Timing is Not eXACT: Implications for Autism Spectrum Disorders
por: LaSalle, Janine M.
Publicado: (2022)

Epigenomic signatures reveal mechanistic clues and predictive markers for autism spectrum disorder
por: LaSalle, Janine M.
Publicado: (2023)

Identifying Biomarkers of Spinal Muscular Atrophy for Further Development
por: Glascock, Jacqueline, et al.
Publicado: (2023)

The Promise of DNA Methylation in Understanding Multigenerational Factors in Autism Spectrum Disorders
por: Mouat, Julia S., et al.
Publicado: (2022)

Human SHQ1 variants R335C and A426V lead to severe ribosome biogenesis defects when expressed in yeast
por: Alidou-D’Anjou, Ismaël, et al.
Publicado: (2023)

Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study
por: Kolb, Stephen J., et al.
Publicado: (2016)

The Role of MeCP2 in Brain Development and Neurodevelopmental Disorders
por: Gonzales, Michael L., et al.
Publicado: (2010)

Future Prospects for Epigenetics in Autism Spectrum Disorder
por: Williams, Logan A., et al.
Publicado: (2022)

Epigenetics in Prader-Willi Syndrome
por: Mendiola, Aron Judd P., et al.
Publicado: (2021)

Carrier screening for spinal muscular atrophy
por: Prior, Thomas W.
Publicado: (2008)

UBE3A: An E3 Ubiquitin Ligase With Genome-Wide Impact in Neurodevelopmental Disease
por: Lopez, Simon Jesse, et al.
Publicado: (2019)

Essential competencies for physical therapist managing individuals with spinal muscular atrophy: A delphi study
por: Timmerberg, Jean Fitzpatrick, et al.
Publicado: (2021)

Spinal Muscular Atrophy: Mutations, Testing, and Clinical Relevance
por: Keinath, Melissa C, et al.
Publicado: (2021)

An overview of the Cure SMA membership database: Highlights of key demographic and clinical characteristics of SMA members
por: Belter, Lisa, et al.
Publicado: (2018)

The stability and control of discrete processes
por: LaSalle, J P
Publicado: (1986)

Comethyl: a network-based methylome approach to investigate the multivariate nature of health and disease
por: Mordaunt, Charles E, et al.
Publicado: (2022)

PACE4-Based Molecular Targeting of Prostate Cancer Using an Engineered (64)Cu-Radiolabeled Peptide Inhibitor()()
por: Couture, Frédéric, et al.
Publicado: (2014)

The Centre H. Becquerel studies in inflammatory non metastatic breast cancer. Combined modality approach in 178 patients.
por: Chevallier, B., et al.
Publicado: (1993)

A novel TTN deletion in a family with skeletal myopathy, facial weakness, and dilated cardiomyopathy
por: Roggenbuck, Jennifer, et al.
Publicado: (2019)

Two steps forward, one step back: current harm reduction policy and politics in the United States
por: Nadelmann, Ethan, et al.
Publicado: (2017)

Stable DNMT3L overexpression in SH-SY5Y neurons recreates a facet of the genome-wide Down syndrome DNA methylation signature
por: Laufer, Benjamin I., et al.
Publicado: (2021)

Emerging therapies and challenges in spinal muscular atrophy
por: Farrar, Michelle A., et al.
Publicado: (2017)

Increased copy number for methylated maternal 15q duplications leads to changes in gene and protein expression in human cortical samples
por: Scoles, Haley A, et al.
Publicado: (2011)

Fully automated system for the quantification of human osteoarthritic knee joint effusion volume using magnetic resonance imaging
por: Li, Wei, et al.
Publicado: (2010)

Expression profiling of clonal lymphocyte cell cultures from Rett syndrome patients
por: Delgado, Ivan J, et al.
Publicado: (2006)

Evaluation of muscle strength and motor abilities in children with type II and III spinal muscle atrophy treated with valproic acid
por: Darbar, Illora A, et al.
Publicado: (2011)

Development of Pityriasis Amiantacea after Valproic Acid Therapy
por: Diaz-Perez, Julio A, et al.
Publicado: (2018)

Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism
por: Swanberg, Susan E., et al.
Publicado: (2009)

Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening
por: Glascock, Jacqueline, et al.
Publicado: (2018)

Contributions to the theory of nonlinear oscillations
por: Cesari, Lamberto, et al.
Publicado: (1960)

The Cure SMA Membership Surveys: Highlights of Key Demographic and Clinical Characteristics of Individuals with Spinal Muscular Atrophy
por: Belter, Lisa, et al.
Publicado: (2021)

Safety, Tolerability, and Effect of Nusinersen in Non-ambulatory Adults With Spinal Muscular Atrophy
por: Elsheikh, Bakri, et al.
Publicado: (2021)

Gene Therapy for Spinal Muscular Atrophy: An Emerging Treatment Option for a Devastating Disease
por: Rao, Vamshi K., et al.
Publicado: (2018)

Peri-operative management of children with spinal muscular atrophy
por: Halanski, Matthew A, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sb74cs6flnk5ik1h71a72al100